Exer AI logo

Exer AI

Clinical AI that improves the quality & efficiency of diagnosis & treatment for MSK and motion disorders.

30 employees · est. 2019 · Denver, United States

VS
MEDGENOME logo

MEDGENOME

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

1011 employees · est. 2013 · Foster City, India

MEDGENOME is the older company (2019 vs 2013); MEDGENOME is the larger of the two.

Side-by-Side Comparison

Exer AI MEDGENOME
Founded
2019 2013 older
Headquarters
Denver, United States Foster City, India
Employees
30 1011 larger
Industry
AI, Health Care, IT Biotechnology, Health Care
Funding Stage
Seed Series D
Total Funding
$11.00M $1.40B
Funding Rounds
3 8
Services
Exer Scan, Exer Health, Exer IQ, Exer Hands, Clinical AI Platform Genetic and Molecular Testing, Omics Solutions, Whole Exome and Genome Sequencing, Liquid Biopsy, Carrier and Hereditary Cancer Screening, Research and Multiomics Services
Target Customers
Healthcare Providers, Clinics, Orthopedics Professionals, Neurologists, Senior Living Facilities, Primary Care Providers, Rehabilitation Centers Clinicians, Hospitals, Pharmaceutical Companies, Patients with Genetic Disorders, Oncology Centers, Reproductive Health Specialists
Taxonomy
Clinical AI, Motion Assessment, Computer Vision, MSK Disorders, Motion Disorders, Orthopedics, Neuro, PM&R (Physical Medicine & Rehabilitation), Pediatrics, Geriatrics, Remote Healthcare, Patient Care Efficiency, Sensorless Technology, At-Home Workout Technology Genomic Testing, Precision Diagnostics, Next-Generation Sequencing, Rare Inherited Disorders, Oncology Genomics, Reproductive Health, Infectious Disease Diagnostics, Preventive Wellness, AI-enabled Bioinformatics, Genomic Healthcare Access, Cancer Genomics, Metabolic Disorders, Eye Disorders, Genomics Research, Immunotherapy Solutions
Website
exer.ai medgenome.com
Exer AI logo

About Exer AI

Exer AI, founded in 2019, is paving the way for advancements in healthcare through its innovative use of Artificial Intelligence and computer vision. Specializing in musculoskeletal (MSK) and motion disorders, their platform enhances diagnostic and treatment processes by offering accurate motion ass...

MEDGENOME logo

About MEDGENOME

MEDGENOME, founded in 2013, has emerged as a leader in the fields of Biotechnology and Health Care, primarily offering comprehensive genetic testing services, genomics research, and drug discovery solutions. Their headquarters is located in India, where they operate South Asia's largest CAP-accredit...

We will tell you when either one moves

BounceWatch watches Exer AI and MEDGENOME for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Exer AI and MEDGENOME — by email.

Frequently Asked Questions

Exer AI — Clinical AI that improves the quality & efficiency of diagnosis & treatment for MSK and motion disorders.. MEDGENOME — Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Exer AI has raised $11.00M while MEDGENOME has raised $1.40B.
Exer AI and MEDGENOME operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Exer AI with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Exer AI on 21 Oct 2025, and MEDGENOME on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes